Skip to search formSkip to main contentSkip to account menu

2 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe [Hyalgan]

Known as: HYALURONATE NA (HYALGAN) 10MG/ML INJ,SYRINGE,2ML, HYALURONATE NA (HYALGAN) 10MG/ML SYR 2ML, Hyalgan 20 MG in 2 ML Prefilled Syringe 
National Institutes of Health

Related topics

Related topics

8 relations
Drug AllergyHyalganPainPrefilled Syringe

Broader (3)

Other antirheumaticsSodium Hyaluronatehyaluronate Prefilled Syringe [Hyalgan]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Nrf2-mediated cytoprotective effect of four different hyaluronic acids by molecular weight in human tenocytes
Abstract Non-traumatic rotator cuff tears (RCTs) are a frequent and potentially disabling injury. There is growing evidence that… 
2018
2018
A Comparison Between Rheological Properties of Intra-articular Hyaluronic Acid Preparations and Reported Human Synovial Fluid
IntroductionThis study aims to compare the properties of currently available intra-articular hyaluronate (IA-HA) products widely… 
2018
2018
Protective therapeutic effects of peptide nanofiber and hyaluronic acid hybrid membrane in in vivo osteoarthritis model.
2018
2018
Intra-articular viscosupplementation of hyaluronic acids in an experimental osteoarthritis model
2017
2017
Long-term clinical benefit and cost-effectiveness of an 8-week multimodal knee osteoarthritis management program incorporating intra-articular sodium hyaluronate (Hyalgan®) injections
Background Given the poor long-term effectiveness of focused nonsurgical knee osteoarthritis (OA) treatments, alternative… 
Review
2010
Review
2010
Viscosupplementation in the management of ankle osteoarthritis: a review
IntroductionOsteoarthritis (OA) is a disease of synovial joints and is the most common cause of chronic pain… 
Review
2008
Review
2008
What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature
IntroductionOsteoarthritis (OA) is a disease of the synovial joints and is the most common cause of chronic pain in the elderly… 
2002
2002
Retrospective Study of Outcomes in Hyalgan®-Treated Patients with Osteoarthritis of the Knee
AbstractObjective: To evaluate therapeutic success [defined as lack of total knee replacement surgery (TKR) or other significant… 
1999
1999
Erratum: Intraarticular sodium hyaluronate (Hyalgan®) in the treatment of patients with osteoarthritis of the knee: A randomized clinical trial (Journal of Rheumatology (1998) 25 (2203-2212))
1992
1992
The intra-articular treatment of osteoarthritis of the knee. A comparison study between hyaluronic acid (Hyalgan®) and orgotein
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)